Table 5. Sensitivity of POU4F2, C1, C2, and C3 in each sub-category of bladder cancer patients.

Sub-category	Sensitivity, % (pos./total)
	POU4F2	C1	C2	C3
TNM
Ta-T1	92.50% (74/80)	92.50% (74/80)	92.50% (74/80)	96.25% (77/80)
T2-T4	86.00% (43/50)	92.00% (46/50)	86.00% (43/50)	92.00% (46/50)
Grade
High	86.11% (31/36)	91.67% (33/36)	86.11% (31/36)	97.22% (35/36)
Low	91.49% (86/94)	92.55% (87/94)	91.49% (86/94)	93.62% (88/94)
Primary/recurrent
Primary	90.10% (91/101)	92.08% (93/101)	90.10% (91/101)	94.06% (95/101)
Recurrent	89.66% (26/29)	93.10% (27/29)	89.66% (26/29)	96.55% (28/29)